Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Cipla
Baxter
UBS
Dow
Boehringer Ingelheim
Federal Trade Commission
McKinsey
AstraZeneca
Deloitte

Generated: October 23, 2017

DrugPatentWatch Database Preview

LIDOCAINE Drug Profile

« Back to Dashboard

What is the patent landscape for Lidocaine, and when can generic versions of Lidocaine launch?

Lidocaine is a drug marketed by Riconpharma Llc, Alkem Labs Ltd, Belmora Llc, Septodont Inc, Teligent Pharma Inc, Vitruvias Therap, Taro, Mylan Technologies, Actavis Labs Ut Inc, Amneal Pharms, Fougera Pharms Inc, Glenmark Pharms Ltd, Tolmar, Fougera Pharms, Hi Tech Pharma, Intl Medication, West-ward Pharms Int, Abraxis Pharm, Bel Mar, Vintage, Hospira, Miles, G And W Labs Inc, Elkins Sinn, Watson Labs, Akorn, Gd Searle Llc, Watson Labs Inc, Mylan Labs Ltd, Luitpold, Abbott, Luitpold Pharms Inc, Wockhardt, Wyeth Ayerst, Dell Labs, Paco, Lyphomed, Baxter Hlthcare, B Braun, Eastman Kodak, Empi, Fresenius Kabi Usa, Aurobindo Pharma Ltd, and Actavis Mid Atlantic. and is included in one hundred and nine NDAs.

The generic ingredient in LIDOCAINE is epinephrine; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.

Summary for Tradename: LIDOCAINE

US Patents:0
Applicants:44
NDAs:109
Suppliers / Packagers: see list32
Bulk Api Vendors: see list71
Clinical Trials: see list925
Patent Applications: see list9,173
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LIDOCAINE at DailyMed

Pharmacology for Tradename: LIDOCAINE

Ingredient-typeAmides
Drug ClassAmide Local Anesthetic
Antiarrhythmic
Physiological EffectLocal Anesthesia
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION087980-001Feb 2, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5%
lidocaine hydrochloride
INJECTABLE;SPINAL083914-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
Hospira
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION088330-001May 17, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Abraxis Pharm
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION080420-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
B Braun
LIDOCAINE HYDROCHLORIDE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
lidocaine hydrochloride
INJECTABLE;INJECTION019830-002Apr 8, 1992APRXNoNo► Subscribe► Subscribe► Subscribe
Eastman Kodak
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION040057-001Feb 26, 1993APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
lidocaine hydrochloride
INJECTABLE;INJECTION088295-001May 17, 1984APRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Inc
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
JELLY;TOPICAL040837-001Mar 23, 2011ATRXNoNo► Subscribe► Subscribe► Subscribe
Hospira
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
epinephrine; lidocaine hydrochloride
INJECTABLE;INJECTION089650-001Jun 21, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Labs Ltd
LIDOCAINE HYDROCHLORIDE
lidocaine hydrochloride
INJECTABLE;INJECTION091058-002Sep 30, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Baxter
Argus Health
Mallinckrodt
Daiichi Sankyo
Dow
Chinese Patent Office
Covington
Farmers Insurance
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot